Massachusetts Telemedicine Laws: License, Rx Rules, Parity

Massachusetts is a full-license state that has not joined the physician compact, has no telehealth registration, and grants no reciprocity. What it offers instead is on the payment side: the 2020 telehealth law wrote audio-only telephone into the definition of telehealth and made behavioral health payment parity permanent for every state-regulated plan and for MassHealth. The parity windows for primary care and chronic disease management were temporary and have closed, which is the distinction that trips up revenue models built on the 2021 headlines.

Licensure: full license, no shortcut

The Board of Registration in Medicine's Policy 20-01, Policy on Telemedicine, as amended in October 2022, sets the location rule: the Board deems a physician to be practicing medicine in Massachusetts when the patient is physically located in Massachusetts. A Massachusetts-licensed physician whose license does not restrict practice to a location may treat Massachusetts patients from anywhere. The Board's own licensing FAQ answers the follow-up question directly — there is no special license for telemedicine, and Massachusetts does not have reciprocity; out-of-state physicians apply for a full license through the ordinary application with an FCVS profile.

The statutory exemptions in M.G.L. c. 112 § 7 are old and narrow: a physician licensed in another state "when in actual consultation with a legal practitioner of the commonwealth," a family physician called to attend a patient temporarily abiding in Massachusetts, and physicians serving athletes at certain sporting events. None supports an ongoing direct-to-patient telehealth relationship.

Massachusetts is not a member of the Interstate Medical Licensure Compact. The current bill, H.2393, was reported favorably by the Joint Committee on Public Health in October 2025 and referred to House Ways and Means, where it remains. The Physical Therapy Compact bill, H.2490, reached House Ways and Means in July 2026 after a favorable report from Health Care Financing. The pattern repeats across professions. Massachusetts has enacted the Nurse Licensure Compact but never implemented it, so no multistate nurse license is available here; its PSYPACT bill has only been introduced; and it has not joined the Counseling Compact. On cross-state practice, Massachusetts is the New England outlier in every one of these professions.

One provision that does help: M.G.L. c. 112 § 5O requires the Board to allow proxy credentialing and privileging for telehealth services with facilities that meet the CMS conditions of participation, and the Board's policy repeats it.

Prescribing: registration, MassPAT, opioid limits and e-prescribing

Policy 20-01 states that the practice of medicine shall not require a face-to-face encounter between physician and patient before care is delivered by telemedicine, and that the standard of care is the same either way. So the treatment relationship can begin online, and prescribing follows the same standard as an office visit.

The Board's FAQ lists the prescribing prerequisites: a Massachusetts license, a federal DEA registration, and a Massachusetts Controlled Substance Registration from the Department of Public Health, with Policy 15-05 as the Board's prescribing-practices guidance. We found no Massachusetts statute that bars a drug schedule by telehealth. Each of the following duties applies to a telehealth prescription exactly as it does in person:

• State registration. M.G.L. c. 94C § 7(a) requires every person who dispenses any controlled substance within the commonwealth to register with the Commissioner of Public Health, and § 1 defines "dispense" to include prescribing. The Department of Public Health issues this Massachusetts Controlled Substances Registration (MCSR). Under 105 CMR 700.004, physicians, physician assistants, nurse practitioners, psychiatric nurse mental health clinical specialists and other listed practitioners must register, separately for each business or professional activity. On receipt of the registration fee, the Commissioner must issue the registration to a physician, nurse practitioner, psychiatric nurse mental health clinical specialist, or other listed practitioner who is duly authorized to practice in the Commonwealth, unless it has been suspended, revoked, or denied for cause (c. 94C § 7(f)). Under 105 CMR 700.004(D), a physician duly authorized to practice in Massachusetts is registered automatically, but only for Massachusetts Schedule VI and for the same schedules as the physician's DEA registration. The MCSR depends on the Massachusetts license, but it is a separate registration that must be in place before prescribing.
• MassPAT. M.G.L. c. 94C § 24A(c) requires participants to use the prescription monitoring program, MassPAT, before issuing each prescription for a narcotic drug in Schedule II or III or for a benzodiazepine, and lets the Department add Schedule IV or V drugs that are commonly misused. Under 105 CMR 700.012(G), a practitioner must check MassPAT before prescribing any opioid in Schedule II or III or a benzodiazepine, and before prescribing a Schedule IV or V controlled substance that Department guidance designates; "utilize" means accessing and assessing the patient's prescription history, directly or through a delegate. The regulation's exceptions cover care for hospice patients, emergency care where the prescriber judges that a check is likely to harm the patient, situations where a check is not reasonably possible (including temporary technological or electrical failure), a Department waiver, and other exceptions in Department guidance. Chapter 16 of the Acts of 2025 excludes from the program medications that may be prescribed for reproductive or gender-affirming health care services, unless the Department determines that reporting them is necessary to protect the public health. Telepsychiatry groups prescribing benzodiazepines to Massachusetts patients should build the MassPAT check into the visit workflow and check Department guidance for designated Schedule IV and V drugs.
• Opioid limit. M.G.L. c. 94C § 19D limits a first-time outpatient opiate prescription for an adult, and any opiate prescription for a minor, to a 7-day supply, and the prescriber must discuss the risks of opiate use and the reasons for the prescription with a minor's parent or guardian. A larger supply is allowed when, in the practitioner's professional medical judgment, it is required for an acute medical condition or necessary for chronic pain management, cancer-related pain or palliative care; the condition must be documented in the medical record along with the practitioner's indication that a non-opiate alternative was not appropriate. The limit does not apply to medications designed for the treatment of substance abuse or opioid dependence.
• Supply and refill limits. Under M.G.L. c. 94C § 23, a Schedule II prescription becomes invalid 30 days after it is issued and may not be refilled. Unless another statute prohibits it, a Schedule II or III prescription may be filled for up to a 90-day supply at a time for opioid use disorder treatment such as buprenorphine, for non-opioid controlled substances such as methylphenidate and testosterone, and for implantable infusion pumps; every other Schedule II or III prescription is limited to a 30-day supply per filling, and the Department may set a shorter limit by regulation to address increased abuse of a substance (§ 23(d)).
• E-prescribing. M.G.L. c. 94C § 23(g) requires prescribers to "issue an electronic prescription for all controlled substances and medical devices." Under § 23(h), the Commissioner sets the exceptions by regulation, and they are limited to veterinarians' prescriptions, temporary technological or electrical failure, time-limited waivers for economic hardship, technological limitations outside the practitioner's reasonable control or other exceptional circumstances, emergencies as the Commissioner defines them (including where e-prescribing would cause a delay that harms the patient), prescriptions that cannot be issued electronically under federal or state law, prescriptions issued outside the jurisdiction of the commonwealth, and other exceptions the Commissioner adopts after reporting to the Legislature. The Department's regulation, 105 CMR 721.070(A), lists twelve exceptions, including prescriptions issued outside the jurisdiction of the Commonwealth, Schedule VI prescriptions, compounded preparations, and prescriptions for a declared public health emergency or an urgent public health matter, and bars using any exception to circumvent the electronic prescription requirement. An oral prescription for a Schedule II–V substance issued under an exception must be followed by a written or electronic prescription within seven business days (105 CMR 721.070(B)). Medicare Part D separately requires at least 70 percent of Part D Schedule II–V prescriptions to be electronic under 42 CFR 423.160, subject to exceptions and waivers.

Federal law adds a separate layer for controlled substances. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), which runs through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without a prior in-person evaluation, when the rule's other conditions are met; audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder. See our guide to federal telehealth laws.

Consent: a standard, not a form

Massachusetts has no standalone telehealth consent statute. Chapter 260 handled it by reference: each insurance section, and the MassHealth section, states that services provided via telehealth "shall conform to the standards of care applicable to the telehealth provider's profession and specialty" and to applicable privacy and security standards "as well as standards for informed consent." The same sections give the patient the right to decline telehealth and receive in-person services, and bar plans from requiring providers to document a barrier to an in-person visit.

For MassHealth members, All Provider Bulletin 379 requires the provider to obtain the member's consent to receive services via telehealth and to tell the member about relevant privacy considerations and that the consent may be revoked at any time. The provider must also tell the patient where the provider is located, obtain the patient's location, and tell the patient how to see a clinician in person in an emergency or as otherwise needed. The Board's telemedicine policy is silent on consent format, so verify with the Board whether verbal consent documented in the chart satisfies its expectations for your specialty.

Medicaid: parity by statute, audio-only included

M.G.L. c. 118E § 79 requires MassHealth and the health plans and other entities it contracts with to cover services delivered via telehealth by a contracted health care provider when the same service is covered in person and may be appropriately provided that way. MassHealth may apply utilization review, including preauthorization, to decide whether telehealth is appropriate, made in the same manner as for in-person care, and neither MassHealth nor its contracted plans must reimburse a provider not contracted under the plan, except as provided in c. 176O § 6(a)(4)(i) (c. 118E § 79(b)–(c)). In-network behavioral health delivered by interactive audio-video or audio-only telephone must be paid at no less than the in-person rate, and the statute allows video and audio-only to pay more than other telehealth modalities. Cost sharing cannot exceed the in-person amount.

Operationally, MassHealth's policy is All Provider Bulletin 379 (October 2023), which amends and restates its earlier telehealth bulletins and applies to all MassHealth programs as of October 1, 2023. Enrolled providers may deliver covered services by audio-only, live video, and asynchronous visits when they judge it clinically appropriate and the member consents, and MassHealth pays them at the same rates as in-person services. Professional claims use place-of-service code 10 for the member's home and 02 for other settings, with modifier 95 for audio-video counseling and therapy, 93 for audio-only services, FQ for audio-only counseling and therapy, FR when a supervising practitioner is present by audio-video, and GQ for asynchronous services; institutional claims require modifier GT. Providers may not bill a facility claim for the originating site, and both the member's and the practitioner's sites must be in the United States or its territories. Services that cannot be delivered by any telehealth modality include ambulance, ambulatory surgery, anesthesia, chiropractic, hearing aid, inpatient hospital, laboratory, nursing facility, orthotic, personal care, prosthetic, renal dialysis clinic, surgery, transportation, and X-ray and radiology services. The bulletin covers fee-for-service, the PCC Plan, MCOs, Accountable Care Partnership Plans, and Primary Care ACOs; it said remote patient monitoring coverage would come later, so confirm current RPM coverage with MassHealth.

Private insurance: read the sunsets

Chapter 260 inserted matching telehealth sections into M.G.L. c. 175 § 47MM (insurers), c. 176A § 38, c. 176B § 25, c. 176G § 33 (HMOs), and c. 32A § 30 (state employees). The permanent baseline is coverage parity inside the plan's network. A plan must cover health care services delivered via telehealth by a contracted health care provider if it covers the services in person and they may be appropriately provided through telehealth. It need not reimburse a provider not contracted under the plan, except where a medically necessary covered service is not available in the carrier's network and c. 176O § 6(a)(4)(i) requires out-of-network coverage. Coverage may include utilization review, including preauthorization, to decide whether telehealth is appropriate, as long as the determination is made "in the same manner as if the service was delivered in-person." A plan may not meet network adequacy through significant reliance on telehealth providers and does not have an adequate network if patients cannot get appropriate in-person services in a timely manner on request (c. 175 § 47MM(b)–(c)). Cost sharing may not exceed the in-person amount, and coverage may not be limited to third-party telehealth vendors.

Audio-only telephone sits inside the statutory definition of telehealth, so the coverage rule reaches it. On rates, the five commercial and state-employee sections let a plan pay more for interactive audio-video than for other modalities, audio-only included (c. 175 § 47MM(e) and its counterparts); the MassHealth section lets both audio-video and audio-only pay more than other modalities (c. 118E § 79(e)). The permanent behavioral health payment rule below names audio-only expressly.

Payment parity is where the law splits. Subsection (g) of each section makes it permanent for behavioral health: in-network behavioral health delivered by interactive audio-video or audio-only telephone must be paid at no less than the in-person rate, with no expiration. Everything else was time-limited and uncodified. Section 68 of the act required in-person rates for all telehealth services, and Section 77 repealed it 90 days after the COVID-19 state of emergency ended. Section 69 required in-person rates for primary care and chronic disease management, and Sections 76 and 78 repealed it two years from the act's effective date — the act was approved January 1, 2021, so that window closed at the start of 2023. For those services, rates are now whatever the contract says; some carriers kept parity voluntarily, others did not, so model from your actual fee schedules. The broader picture is in our reimbursement guide.

What to watch

Three items. First, H.2393, the IMLC bill, in House Ways and Means — if it moves in the closing months of the 2025–2026 session, Massachusetts stops being the New England outlier on physician licensure. Second, H.5017, "An Act relative to telehealth and digital equity for patients," which the Financial Services Committee reported in February 2026 and which now sits in Health Care Financing with a reporting deadline extended to the end of 2026; watch whether it revisits the expired parity windows. Third, the federal side: the DEA's telemedicine prescribing framework and Medicare's telehealth flexibilities set what Massachusetts's lack of an in-person prerequisite is worth — verify current status before building on either. Verify current requirements with the Board of Registration in Medicine and MassHealth before acting, and compare Massachusetts with its neighbors in the national overview.